Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2020-11-01
|
| Series: | Gastroenterology Review |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841548278233038848 |
|---|---|
| author | Magdalena Kaniewska Mariusz Rosołowski Andrzej Moniuszko Grazyna Rydzewska |
| author_facet | Magdalena Kaniewska Mariusz Rosołowski Andrzej Moniuszko Grazyna Rydzewska |
| author_sort | Magdalena Kaniewska |
| collection | DOAJ |
| format | Article |
| id | doaj-art-056b43fddc1543e0b847bbc4655f210d |
| institution | Kabale University |
| issn | 1895-5770 1897-4317 |
| language | English |
| publishDate | 2020-11-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Gastroenterology Review |
| spelling | doaj-art-056b43fddc1543e0b847bbc4655f210d2025-01-10T14:06:17ZengTermedia Publishing HouseGastroenterology Review1895-57701897-43172020-11-0116320721210.5114/pg.2020.10075042377Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patientsMagdalena KaniewskaMariusz RosołowskiAndrzej MoniuszkoGrazyna Rydzewskahttps://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.htmlinflammatory bowel disease crohn’s disease biological treatment biosimilar anti-tnf-α naïve infliximab. |
| spellingShingle | Magdalena Kaniewska Mariusz Rosołowski Andrzej Moniuszko Grazyna Rydzewska Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients Gastroenterology Review inflammatory bowel disease crohn’s disease biological treatment biosimilar anti-tnf-α naïve infliximab. |
| title | Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients |
| title_full | Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients |
| title_fullStr | Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients |
| title_full_unstemmed | Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients |
| title_short | Biosimilar infliximab versus originator in Crohn’s
disease anti-TNF-α naïve and non-naïve patients |
| title_sort | biosimilar infliximab versus originator in crohn s disease anti tnf α naive and non naive patients |
| topic | inflammatory bowel disease crohn’s disease biological treatment biosimilar anti-tnf-α naïve infliximab. |
| url | https://www.termedia.pl/Biosimilar-infliximab-versus-originator-in-Crohn-s-r-ndisease-anti-TNF-naive-and-non-naive-patients,41,42377,1,1.html |
| work_keys_str_mv | AT magdalenakaniewska biosimilarinfliximabversusoriginatorincrohnsdiseaseantitnfanaiveandnonnaivepatients AT mariuszrosołowski biosimilarinfliximabversusoriginatorincrohnsdiseaseantitnfanaiveandnonnaivepatients AT andrzejmoniuszko biosimilarinfliximabversusoriginatorincrohnsdiseaseantitnfanaiveandnonnaivepatients AT grazynarydzewska biosimilarinfliximabversusoriginatorincrohnsdiseaseantitnfanaiveandnonnaivepatients |